Conformationally restricted inhibitors of the high affinity -glutamate transporter
A series of acidic amino acids has been prepared and evaluated in an effort to identify the structural features required for binding to and inhibiting the high affinity uptake system that clears L-glutamate from the synaptic cleft during excitatory amino acid-mediated neurotransmission in the mammalian CNS. Modeling studies have identified a putative pharmacophore for the NA++-dependent synaptosomal glutamate transporter.
References (19)
Neuron
(1988)- et al.
Brain Res. Bull.
(1983) - et al.
J. Neurosci.
(1992) - et al.
Neurosci. Lett.
(1986) - et al.
Trends Pharmac. Sci.
(1990)et al.J. Med. Chem.
(1992) - et al.
Neurosci. Lett.
(1991) - et al.
J. Med. Chem.
(1991)Ph. D. Thesis
(1989)et al.Neuroscience Lett.
(1988) - et al.
J. Org. Chem.
(1990)
Cited by (57)
Organocatalytic synthesis of enantiopure spiro acenaphthyl-pyrrolizidine/pyrrolidines: Justifying the regioselectivity based on a distortion/interaction model
2019, Organic and Biomolecular ChemistryA facile and stereoselective synthesis of the C-2 epimer of (+)-deacetylanisomycin
2011, Tetrahedron AsymmetryCitation Excerpt :Anisomycin 1 was found to exhibit selective and potent activities against pathogenic protozoa and certain strains of fungi7 and it is currently being used in clinical trials for the treatment of amoebic dysentery and vaginitis. More recently it was reported that anisomycin 1 had been identified as an antitumor substance showing in vitro cytotoxicity against human tumour lines, such as mammalian cell lines HBL 100, RAS A and MCF 7 in the nanomolar region.3,8 Both anisomycin 1 and its deacetylderivative 1a have been used as fungicides in the eradication of bean mildew and for the inhibition of other pathogenic fungi in plants.9